Literature DB >> 23695054

Migraine and pregnancy: an internet survey.

Gianni Allais1, Sara Rolando, Cristina De Lorenzo, Gian Camillo Manzoni, Paolo Messina, Chiara Benedetto, Florindo d'Onofrio, Vincenzo Bonavita, Gennaro Bussone.   

Abstract

Data in the literature show that migraine tends to improve during pregnancy in most migrainous women. The aim of this Internet survey was to obtain the most likely cross section of the situation in the general population with respect to the presence and course of migraine in pregnancy. All women who participated were asked to answer questions pertaining to their history of pregnancy and headache. One thousand and eighteen women participated in the survey; only 775 met the eligibility criteria for inclusion. One hundred and ninety-five women (25.2 %) reported having had a headache only before pregnancy, 425 (54.8 %) before and during pregnancy, and 155 (20.0 %) only during pregnancy. Women suffering from headache before and/or during pregnancy were much more likely to have headaches with more migrainous features at the ID Migraine Screener test when compared to women whose headache began during pregnancy. "Definite migraines" were 277/620 (44.7 %) and 26/155 (16.8 %), respectively, in the two groups (p < 0.0001). Among the 620 females that suffered from headache before pregnancy, 375 (60.5 %) improved, 195 (31.5 %) showed complete resolution of the disorder, and 180 (29.0 %) had a reduction in headache frequency. Moreover, the multinomial logistic model (with headache pattern as dependent variable) proved fetal presentation as significant (p = 0.0042). Women with "new headache" (No/Yes pattern) had an OR (95 % CI) of 1.9 (1.2-3.0) of breech presentation at delivery versus those with a stable pattern of headache (Yes/Yes). Finally, women with not recent pregnancy stated they suffered from headache less than the women with recent pregnancy.

Entities:  

Mesh:

Year:  2013        PMID: 23695054     DOI: 10.1007/s10072-013-1394-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  6 in total

1.  Migraine attacks in the pharmacy: a gender subanalysis on treatment preferences.

Authors:  P Brusa; G Allais; S Rolando; F Baratta; M Giaccone; G Bussone; R Allais; C Benedetto
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

2.  Patterns and predictors of analgesic use in pregnancy: a longitudinal drug utilization study with special focus on women with migraine.

Authors:  Gerd-Marie Eskerud Harris; Mollie Wood; Malin Eberhard-Gran; Christofer Lundqvist; Hedvig Nordeng
Journal:  BMC Pregnancy Childbirth       Date:  2017-07-14       Impact factor: 3.007

3.  Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women.

Authors:  Siri Amundsen; Torunn G Øvrebø; Netta Marie S Amble; Anne Christine Poole; Hedvig Nordeng
Journal:  Eur J Clin Pharmacol       Date:  2016-09-13       Impact factor: 2.953

4.  First nationwide web-based surveillance system for influenza-like illness in pregnant women: participation and representativeness of the French G-GrippeNet cohort.

Authors:  Paul Loubet; Caroline Guerrisi; Clément Turbelin; Béatrice Blondel; Odile Launay; Marc Bardou; Thierry Blanchon; Isabelle Bonmarin; François Goffinet; Pierre-Yves Ancel; Vittoria Colizza; Thomas Hanslik; Solen Kernéis
Journal:  BMC Public Health       Date:  2016-03-11       Impact factor: 3.295

5.  Risk perception, beliefs about medicines and medical adherence among pregnant and breastfeeding women with migraine: findings from a cross-sectional study in Norway.

Authors:  Siri Amundsen; Torunn Gudmestad Øvrebø; Netta Marie Skretteberg Amble; Anne Christine Poole; Hedvig Nordeng
Journal:  BMJ Open       Date:  2019-02-27       Impact factor: 2.692

6.  Characteristics of menstrual versus non-menstrual migraine during pregnancy: a longitudinal population-based study.

Authors:  Beáta Éva Petrovski; Kjersti G Vetvik; Christofer Lundqvist; Malin Eberhard-Gran
Journal:  J Headache Pain       Date:  2018-04-02       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.